一种类似于Elastin的聚聚合,向囊体-体接口,作为抗病毒药物,对抗细胞巨型病毒感染

相关实验视频

Updated: Jun 27, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

Komal Beeton¹, Dipanwita Mitra¹, Adesanya A Akinleye²

¹Department of Cell and Molecular Biology, Center for Immunology and Microbial Research, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, USA.

Scientific reports

|May 4, 2024

概括

一种针对人类细胞巨乳病毒 (HCMV) 成熟的新型 (P10) 与弹性类多 (ELP) 融合,形成ELP-P10. 这种融合增强了的生物可用性,并在HCMV感染的小鼠模型中显著降低了病毒载量.

科学领域:

病毒学病毒学
生物技术是生物技术.
药理学药理学是指药理学的学科.

背景情况:

人类细胞巨病毒 (HCMV) 体蛋白pp150对于病毒成熟至关重要.
针对pp150-capsid相互作用的可以抑制病毒生长.
的药理动力学限制阻碍了体内抗病毒开发.

研究的目的:

提高针对HCMV的抗病毒 (P10) 的生物可用性和有效性.
在体内评估一种类似弹性素的多 (ELP) -P10融合结构的药理动力学和抗病毒特性.

主要方法:

设计和制造了一种ELP-P10融合蛋白.
在细胞培养中评估ELP-P10的抗病毒活性和细胞毒性.
在CMV感染的小鼠模型中研究了药理动力学,生物分布和抗病毒疗效.

主要成果:

在细胞培养中ELP-P10表现出显著的抗病毒活性.
与ELP的结合增强了P10的生物可用性和组织积累 (肝脏,脏).
治疗ELP-P10显著降低了感染小鼠的重要器官中的病毒标位.

结论:

ELP-P10融合结构有效地提高了的生物可用性和对CMV的抗病毒功效.
ELP-P10显示出作为CMV感染治疗剂的潜力.

更多相关视频

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

相关概念视频

Viral Structure

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.